Operater of a cell therapy company intended to develop novel cell therapies for patients with solid tumors and no treatment options. The company specializes in the development of chimeric antigen rece...

Healthcare
London, United Kingdom
Founded 2014
24 employees
Website
Valuation
$25M
Latest known
Share Price
N/A
Total Raised
$30.8M
Last Round
N/A